Health IT & Digital Health-Opinion | Op-Eds | Guest Columns | Analysis, Insights - HIT Consultant

Is It Time We Stifle Innovation in Healthcare?

by Leave a Comment

Should we stifle innovation in healthcare or should we attempt to disseminate between healthcare innovations that seems worthy? Margarit Gur-Arie explains. Stifling innovation is a very bad thing. As a society it is incumbent upon us to let innovation breath free, prosper and multiply, because innovation is good for us. All innovation is good for us, even if it doesn’t look that way initially, because you never know when a seemingly useless innovation will spawn that one innovation that will
Read More

Electronic Medical Records–Past, Present and Future?

by 6 Comments

Dr. Donald Voltz, MD discusses how the electronic medical records of today is merely a duplication of the past and how future EMR systems must align medical professionals with data that needs to be collaborative.  The open question regarding Electronic Medical Records (EMRs) is what they now offer the medical community and what would medical professionals need and envision for the next generation. The Henry Ford adage: “If I had asked people what they wanted, they would have said
Read More

We Must All be Engaged in the Design, Delivery, and Re-imagination of Healthcare

by 8 Comments

On a recent flight, I had my headphones on and the Rolling Stones’ “Satisfaction” began to play.  It’s a song I have heard hundreds of times over the years, but I was struck by the difference listening to it with headphones made.  With no distractions, I noticed the bass line, in time with the percussion, provides the perfect offset to Mick Jagger’s distinctively strained voice.  It was a completely different experience than hearing the track play in the background of a movie or while at a
Read More

Jonathan Bush Urges Pharma to Take a New Look at the Pharma Business Model

by 3 Comments

Jonathan Bush tells it like it is to pharma by Lois Drapin, CEO, The Drapin Group LLC When I saw that Jonathan Bush was going to present at IIR’s ePharma Summit in NYC this past February, before he left for his announced leave of absence-sabbatical, I decided I wanted to hear what he was going to say to a room full of pharma marketers, brand leaders, and the digerati of pharma and its ecosystems of agencies and consultants. Wherever Mr. Bush is on stage, and I have seen him many times over
Read More